Clinical Trial Update: Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care

View source ↗

Summary

A completed trial evaluated VISIPAQUE-enhanced computed tomography angiography in patients suspected of coronary artery disease during routine medical care. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• VISIPAQUE (IODIXANOL)

Snippet

Sponsor: GE Healthcare | Conditions: Coronary Artery Disease (CAD) | Status: COMPLETED | Results posted: 2014-12-11